Key facts
- Bloom43’s last known valuation is $19.1M (Jul 2025).
- It has raised $6.6M.
- Notable investors include Innovate UK, MedTech Innovator, Texas Medical Center, ScaleUps Ventures, TCP Health Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Bloom43
- ·The full record, as it builds
Funding rounds
No funding rounds for Bloom43 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bloom43
Developer of supraphysiological preconditioning device designed to heal the body from surgery complications. The company's device helps people to prepare and pre-emptively protect their bodies before surgery through preconditioning therapy, enabling patients to achieve a complication-free experience of surgery.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 10
- Website
- bloom43.com/
- Ownership
- Privately Held (backing)
Bloom43 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bloom43 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bloom43 in its N-PORT filings yet. We sweep new filings monthly.